These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 18829721

  • 1. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA.
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.
    Bliziotis IA, Plessa E, Peppas G, Falagas ME.
    Ann Pharmacother; 2010 Jan; 44(1):97-106. PubMed ID: 19934396
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ, Lamp KC.
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [Abstract] [Full Text] [Related]

  • 5. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].
    Mathiesen L, Midtvedt T, Solberg CO.
    Tidsskr Nor Laegeforen; 2006 Sep 21; 126(18):2383-4. PubMed ID: 16998552
    [Abstract] [Full Text] [Related]

  • 6. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M, Russo A, Pompeo ME, Vena A, Marruncheddu L, Ciccaglioni A, Grossi P, Mancini C, Novelli A, Stefani S, Venditti M.
    Int J Antimicrob Agents; 2012 Jan 21; 39(1):64-8. PubMed ID: 22047703
    [Abstract] [Full Text] [Related]

  • 7. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ, Smith N, Bradsher RW, Menon A.
    Clin Infect Dis; 2007 Mar 15; 44(6):777-84. PubMed ID: 17304447
    [Abstract] [Full Text] [Related]

  • 8. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children.
    Teng CS, Lo WT, Wang SR, Tseng MH, Chu ML, Wang CC.
    J Microbiol Immunol Infect; 2009 Aug 15; 42(4):324-8. PubMed ID: 19949756
    [Abstract] [Full Text] [Related]

  • 9. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM, Weigelt J, Li JZ, Duttagupta S.
    Int J Antimicrob Agents; 2005 Dec 15; 26(6):442-8. PubMed ID: 16289514
    [Abstract] [Full Text] [Related]

  • 10. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
    Davis SL, McKinnon PS, Hall LM, Delgado G, Rose W, Wilson RF, Rybak MJ.
    Pharmacotherapy; 2007 Dec 15; 27(12):1611-8. PubMed ID: 18041881
    [Abstract] [Full Text] [Related]

  • 11. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T, Alan T.
    Hawaii Med J; 2006 Oct 15; 65(10):290-3. PubMed ID: 17194061
    [Abstract] [Full Text] [Related]

  • 12. Treatment of staphylococcal infections with cyclic lipopeptides.
    Eisenstein BI.
    Clin Microbiol Infect; 2008 Mar 15; 14 Suppl 2():10-6. PubMed ID: 18226085
    [Abstract] [Full Text] [Related]

  • 13. Pre-clinical experience with daptomycin.
    Hawkey PM.
    J Antimicrob Chemother; 2008 Nov 15; 62 Suppl 3():iii7-14. PubMed ID: 18829726
    [Abstract] [Full Text] [Related]

  • 14. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Awad SS, Elhabash SI, Lee L, Farrow B, Berger DH.
    Am J Surg; 2007 Nov 15; 194(5):606-10. PubMed ID: 17936421
    [Abstract] [Full Text] [Related]

  • 15. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1107-17. PubMed ID: 17040922
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic options for treating community-acquired MRSA.
    Powell JP, Wenzel RP.
    Expert Rev Anti Infect Ther; 2008 Jun 15; 6(3):299-307. PubMed ID: 18588495
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF, Frank AL.
    Expert Rev Anti Infect Ther; 2006 Feb 15; 4(1):91-100. PubMed ID: 16441212
    [Abstract] [Full Text] [Related]

  • 18. Daptomycin.
    Enoch DA, Bygott JM, Daly ML, Karas JA.
    J Infect; 2007 Sep 15; 55(3):205-13. PubMed ID: 17629567
    [Abstract] [Full Text] [Related]

  • 19. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
    Rouse MS, Piper KE, Jacobson M, Jacofsky DJ, Steckelberg JM, Patel R.
    J Antimicrob Chemother; 2006 Feb 15; 57(2):301-5. PubMed ID: 16361330
    [Abstract] [Full Text] [Related]

  • 20. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA.
    Ann Emerg Med; 2008 Mar 15; 51(3):291-8. PubMed ID: 18222564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.